OUR BLOG
Insights
-
Tiago Oliveira on Antibodies for Understanding Cancer Biology Through Glycoproteomics
We chatted with Tiago Oliveira, a PhD candidate at Griffith University, on antibodies for glycoprpteomic cancer studies.
-
Phenomic AI Tackles Drug Discovery with AI-driven High-throughput Phenotypic Screens Using Antibody-based Assays
Phenomic AI conducts high-throughput phenotypic screens using artificial intelligence to analyze the resulting microscopy images. I sat down with three Phenomic AI biologists, Allison Nixon, Max London, and Elizabeth Koch, to learn more about the company and it’s technology.
-
Omer Donmez on Antibodies for Elucidating the Roles of Transcription Factors in Lupus Etiology
We chatted with Omer Donmez, a Research Technician at CCHMC, on antibodies for studying transcription factors, and how BenchSci has helped.
-
Naheed Kurji, CEO of Cyclica, on Building an AI Platform to Design, Screen, and Personalize Drugs
Cyclica predicts a drug’s polypharmacology to provide insights into adverse effects, repurposing, and more. Learn polypharmacology’s challenges and opportunities, how AI is necessary—but not sufficient—to address them, and opportunities in drug discovery driven by computing and genomics advances.
-
Nick Lynch of the Pistoia Alliance on AI as a Strategic Focus
For this episode of the Artificial Intelligence in Drug Discovery podcast, I speak with Nick Lynch of the Pistoia Alliance, a global nonprofit community of life science stakeholders that works to lower barriers to R&D innovation. A new area of strategic focus is AI, which Nick oversees.
-
Lucas Siow of ProteinQure on AI for Protein-Based Drugs
For this episode of the Artificial Intelligence in Drug Discovery podcast, I speak with Lucas Siow of ProteinQure on how they’re combining quantum computing, reinforcement learning, and molecular simulations to design protein-based therapeutics.
-
Stephanie Guerra on Antibodies for Characterizing Novel Combination Therapies for KRAS-mutant Lung Adenocarcinoma
We chatted with Stephanie Guerra, a postdoctoral fellow at Harvard University, on antibodies for her research, and her experience with BenchSci.
-
Regina Barzilay on AI for Small Molecule Discovery and Synthesis
For this episode of the Artificial Intelligence in Drug Discovery podcast, I speak with Regina Barzilay, prolific machine learning researcher, on automating small molecule discovery and synthesis.
-
Tim Guilliams and David Brown, Healx, on AI for Rare Diseases
For this episode of the Artificial Intelligence in Drug Discovery podcast, I speak with Tim Guilliams and David Brown of Healx. Healx uses AI to repurpose existing drugs for rare diseases.